STRATA Skin Sciences to Participate in the Oppenheimer MedTech, Tools & Diagnostics Summit
HORSHAM, Pa. , May 18, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced the Company will participate in the
STRATA Skin Sciences Reports First Quarter 2021 Financial Results
HORSHAM, Pa. , May 12, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced financial results for the quarter ended
STRATA Skin Sciences to Report First Quarter 2021 Financial Results on May 12, 2021
HORSHAM, Pa. , April 28, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced that it
STRATA Skin Sciences Appoints William D. Humphries to Its Board of Directors
HORSHAM, Pa. , April 12, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced the appointment of William D.
STRATA Skin Sciences Reports Fourth Quarter and Full Year 2020 Financial Results
HORSHAM, Pa. , March 24, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced financial
STRATA Skin Sciences to Present at the Lytham Partners Spring 2021 Investor Conference
HORSHAM, Pa. , March 16, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA”) (NASDAQ: SSKN), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today
STRATA Skin Sciences Announces Independent Study Published in the Journal of The European Academy of Dermatology and Venereology
Vitiligo Repigmentation Achieved in Five Treatments with XTRAC® Excimer Laser HORSHAM, Pa. , March 15, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: SSKN) STRATA Skin Sciences, Inc. (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and
STRATA Skin Sciences to Report Fourth Quarter and Full Year 2020 Financial Results on March 24, 2021
HORSHAM, Pa. , March 10, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it
STRATA Skin Sciences Announces Expanded Distribution Agreement in China with Wuhan Miracle Laser Systems, Inc.
New Agreement Expands STRATA's Global Reach and Brings Successful Recurring Revenue Model to the Chinese Dermatology Market HORSHAM, Pa. , March 09, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: SSKN) STRATA Skin Sciences, Inc. (“STRATA”), a medical technology company in Dermatology and Plastic Surgery
STRATA Skin Sciences, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
HORSHAM, Pa. , March 01, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences , Inc. (NASDAQ: SSKN) (the “Company”) a medical technology company in dermatology and plastic surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions,